Su, Min-Ying

Title(s)Professor, Radiological Sciences
Phone(949) 824-4925
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Mammographic Density and Metabolic Genotyping for Predicting Cancer Prognosis
    NIH/NCI R21CA208938Aug 1, 2017 - Jul 31, 2019
    Role: Principal Investigator
    Volume and Morphology of Fibroglandular Tissue for Breast Cancer Risk Prediction
    NIH/NCI R21CA170955Jan 15, 2013 - Dec 31, 2014
    Role: Principal Investigator
    Combined MRI and Optical Imaging to Improved Breast Cancer Diagnosis
    NIH/NCI R21CA121568Aug 1, 2007 - Jul 31, 2010
    Role: Principal Investigator
    Predicting Neoadjuvant Chemo Response/Prognosis Using Imaging Biomarkers
    NIH/NCI R01CA127927Apr 1, 2007 - Mar 31, 2018
    Role: Principal Investigator
    NIH/NIA R01AG017066Apr 15, 2001 - Mar 31, 2007
    Role: Principal Investigator
    NIH/NIA R03AG015539Sep 30, 1998 - Sep 29, 1999
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Zhang Y, Chen JH, Chang KT, Park VY, Kim MJ, Chan S, Chang P, Chow D, Luk A, Kwong T, Su MY. Automatic Breast and Fibroglandular Tissue Segmentation in Breast MRI Using Deep Learning by a Fully-Convolutional Residual Neural Network U-Net. Acad Radiol. 2019 Jan 31. PMID: 30713130.
      View in: PubMed
    2. Chen JH, Zhang Y, Chan S, Chang RF, Su MY. Quantitative analysis of peri-tumor fat in different molecular subtypes of breast cancer. Magn Reson Imaging. 2018 Nov; 53:34-39. PMID: 29969646.
      View in: PubMed
    3. Skarecky D, Yu H, Linehan J, Morales B, Su MY, Fwu P, Ahlering T. Hypothermic Cooling Measured by Thermal Magnetic Resonance Imaging; Feasibility and Implications for Virtual Imaging in the Urogenital Pelvis. Urology. 2017 Oct; 108:220-224. PMID: 28733200.
      View in: PubMed
    4. McLaren CE, Chen WP, O'Sullivan TD, Gillen DL, Su MY, Chen JH, Tromberg BJ. Sample size and power determination when limited preliminary information is available. BMC Med Res Methodol. 2017 Apr 26; 17(1):75. PMID: 28446127.
      View in: PubMed
    5. Wang J, Fang Z, Lang N, Yuan H, Su MY, Baldi P. A multi-resolution approach for spinal metastasis detection using deep Siamese neural networks. Comput Biol Med. 2017 05 01; 84:137-146. PMID: 28364643.
      View in: PubMed
    6. Chen JH, Liao F, Zhang Y, Li Y, Chang CJ, Chou CP, Yang TL, Su MY. 3D MRI for Quantitative Analysis of Quadrant Percent Breast Density: Correlation with Quadrant Location of Breast Cancer. Acad Radiol. 2017 07; 24(7):811-817. PMID: 28131498.
      View in: PubMed
    7. Chen JH, Chan S, Lu NH, Li Y, Tsai YC, Huang PY, Chang CJ, Su MY. Opportunistic Breast Density Assessment in Women Receiving Low-dose Chest Computed Tomography Screening. Acad Radiol. 2016 09; 23(9):1154-61. PMID: 27283069.
      View in: PubMed
    8. Chen JH, Gulsen G, Su MY. Imaging Breast Density: Established and Emerging Modalities. Transl Oncol. 2015 Dec; 8(6):435-45. PMID: 26692524; PMCID: PMC4700291.
    9. Fwu PT, Chen JH, Li Y, Chan S, Su MY. Quantification of Regional Breast Density in Four Quadrants Using 3D MRI-A Pilot Study. Transl Oncol. 2015 Aug; 8(4):250-7. PMID: 26310370; PMCID: PMC4562976.
    10. Lin Y, Lin WC, Fwu PT, Shih TC, Yeh LR, Su MY, Chen JH. Investigation of factors affecting hypothermic pelvic tissue cooling using bio-heat simulation based on MRI-segmented anatomic models. Comput Methods Programs Biomed. 2015 Oct; 122(1):76-88. PMID: 26198131; PMCID: PMC4549219 [Available on 10/01/16].
    11. Chen JH, Yu HJ, Hsu C, Mehta RS, Carpenter PM, Su MY. Background Parenchymal Enhancement of the Contralateral Normal Breast: Association with Tumor Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Transl Oncol. 2015 Jun; 8(3):204-9. PMID: 26055178; PMCID: PMC4487259.
    12. Chen JH, Chan S, Tang YT, Hon JS, Tseng PC, Cheriyan AT, Shah NR, Yeh DC, Lee SK, Chen WP, McLaren CE, Su MY. Impact of positional difference on the measurement of breast density using MRI. Med Phys. 2015 May; 42(5):2268-75. PMID: 25979021; PMCID: PMC4401799.
    13. Bonev V, Evangelista M, Chen JH, Su MY, Lane K, Mehta R, Butler J, Hsiang D. Long-term follow-up of breast-conserving therapy in patients with inflammatory breast cancer treated with neoadjuvant chemotherapy. Am Surg. 2014 Oct; 80(10):940-3. PMID: 25264634; PMCID: PMC4343309.
    14. Ding H, Johnson T, Lin M, Le HQ, Ducote JL, Su MY, Molloi S. Breast density quantification using magnetic resonance imaging (MRI) with bias field correction: a postmortem study. Med Phys. 2013 Dec; 40(12):122305. PMID: 24320536.
      View in: PubMed
    15. Lin M, Chen JH, Wang X, Chan S, Chen S, Su MY. Template-based automatic breast segmentation on MRI by excluding the chest region. Med Phys. 2013 Dec; 40(12):122301. PMID: 24320532; PMCID: PMC3843758.
    16. Chen JH, Bahri S, Mehta RS, Carpenter PM, McLaren CE, Chen WP, Fwu PT, Hsiang DJ, Lane KT, Butler JA, Su MY. Impact of factors affecting the residual tumor size diagnosed by MRI following neoadjuvant chemotherapy in comparison to pathology. J Surg Oncol. 2014 Feb; 109(2):158-67. PMID: 24166728; PMCID: PMC4005994.
    17. Chen JH, Yu H, Lin M, Mehta RS, Su MY. Background parenchymal enhancement in the contralateral normal breast of patients undergoing neoadjuvant chemotherapy measured by DCE-MRI. Magn Reson Imaging. 2013 Nov; 31(9):1465-71. PMID: 23992630; PMCID: PMC3795886.
    18. Chen JH, Pan WF, Kao J, Lu J, Chen LK, Kuo CC, Chang CK, Chen WP, McLaren CE, Bahri S, Mehta RS, Su MY. Effect of taxane-based neoadjuvant chemotherapy on fibroglandular tissue volume and percent breast density in the contralateral normal breast evaluated by 3T MR. NMR Biomed. 2013 Dec; 26(12):1705-13. PMID: 23940080; PMCID: PMC3838444.
    19. Lin M, Fwu PT, Buss C, Davis EP, Head K, Muftuler LT, Sandman CA, Su MY. Developmental changes in hippocampal shape among preadolescent children. Int J Dev Neurosci. 2013 Nov; 31(7):473-81. PMID: 23773912; PMCID: PMC3836360.
    20. Chen JH, Su MY. Clinical application of magnetic resonance imaging in management of breast cancer patients receiving neoadjuvant chemotherapy. Biomed Res Int. 2013; 2013:348167. PMID: 23862143; PMCID: PMC3687601.
    21. Chen JH, Chan S, Yeh DC, Fwu PT, Lin M, Su MY. Response of bilateral breasts to the endogenous hormonal fluctuation in a menstrual cycle evaluated using 3D MRI. Magn Reson Imaging. 2013 May; 31(4):538-44. PMID: 23219249; PMCID: PMC3597749.
    22. Chen JH, Chan S, Liu YJ, Yeh DC, Chang CK, Chen LK, Pan WF, Kuo CC, Lin M, Chang DH, Fwu PT, Su MY. Consistency of breast density measured from the same women in four different MR scanners. Med Phys. 2012 Aug; 39(8):4886-95. PMID: 22894415; PMCID: PMC3411588.
    23. Kuzucan A, Chen JH, Bahri S, Mehta RS, Carpenter PM, Fwu PT, Yu HJ, Hsiang DJ, Lane KT, Butler JA, Feig SA, Su MY. Diagnostic performance of magnetic resonance imaging for assessing tumor response in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy is associated with molecular biomarker profile. Clin Breast Cancer. 2012 Apr; 12(2):110-8. PMID: 22444717; PMCID: PMC3342312.
    24. Chang DH, Chen JH, Lin M, Bahri S, Yu HJ, Mehta RS, Nie K, Hsiang DJ, Nalcioglu O, Su MY. Comparison of breast density measured on MR images acquired using fat-suppressed versus nonfat-suppressed sequences. Med Phys. 2011 Nov; 38(11):5961-8. PMID: 22047360; PMCID: PMC3215688.
    25. Chen JH, Bahri S, Mehta RS, Kuzucan A, Yu HJ, Carpenter PM, Feig SA, Lin M, Hsiang DJ, Lane KT, Butler JA, Nalcioglu O, Su MY. Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging. Radiology. 2011 Dec; 261(3):735-43. PMID: 21878615; PMCID: PMC3219909.
    26. Lin M, Chen JH, Mehta RS, Bahri S, Chan S, Nalcioglu O, Su MY. Spatial shrinkage/expansion patterns between breast density measured in two MRI scans evaluated by non-rigid registration. Phys Med Biol. 2011 Sep 21; 56(18):5865-75. PMID: 21852724; PMCID: PMC3498815.
    27. Lin M, Chan S, Chen JH, Chang D, Nie K, Chen ST, Lin CJ, Shih TC, Nalcioglu O, Su MY. A new bias field correction method combining N3 and FCM for improved segmentation of breast density on MRI. Med Phys. 2011 Jan; 38(1):5-14. PMID: 21361169; PMCID: PMC3017578.
    28. Liao J, Zhu Y, Zhang M, Yuan H, Su MY, Yu X, Wang H. Microstructural white matter abnormalities independent of white matter lesion burden in amnestic mild cognitive impairment and early Alzheimer disease among Han Chinese elderly. Alzheimer Dis Assoc Disord. 2010 Oct-Dec; 24(4):317-24. PMID: 20592582.
      View in: PubMed
    29. Chen JH, Chang YC, Chang D, Wang YT, Nie K, Chang RF, Nalcioglu O, Huang CS, Su MY. Reduction of breast density following tamoxifen treatment evaluated by 3-D MRI: preliminary study. Magn Reson Imaging. 2011 Jan; 29(1):91-8. PMID: 20832226; PMCID: PMC3005955.
    30. Chen JH, Nie K, Bahri S, Hsu CC, Hsu FT, Shih HN, Lin M, Nalcioglu O, Su MY. Decrease in breast density in the contralateral normal breast of patients receiving neoadjuvant chemotherapy: MR imaging evaluation. Radiology. 2010 Apr; 255(1):44-52. PMID: 20308443; PMCID: PMC2843830.
    31. Mehta RS, Su MY. Continued Exploration of Bevacizumab in Breast Cancer. Ann Surg Oncol. 2010 Feb; 17(2):655-6. PMID: 19936837.
      View in: PubMed
    32. Nalcioglu O, Su MY. Foreword. Technol Cancer Res Treat. 2010 Feb; 9(1):1-4. PMID: 20082525; PMCID: PMC4232204.
    33. Nie K, Chang D, Chen JH, Hsu CC, Nalcioglu O, Su MY. Quantitative analysis of breast parenchymal patterns using 3D fibroglandular tissues segmented based on MRI. Med Phys. 2010 Jan; 37(1):217-26. PMID: 20175484; PMCID: PMC2801737.
    34. Nie K, Chang D, Chen JH, Shih TC, Hsu CC, Nalcioglu O, Su MY. Impact of skin removal on quantitative measurement of breast density using MRI. Med Phys. 2010 Jan; 37(1):227-33. PMID: 20175485; PMCID: PMC2801738.
    35. Lin M, Chen JH, Nie K, Chang D, Nalcioglu O, Su MY. Algorithm-based method for detection of blood vessels in breast MRI for development of computer-aided diagnosis. J Magn Reson Imaging. 2009 Oct; 30(4):817-24. PMID: 19787727; PMCID: PMC2789993.
    36. Newell D, Nie K, Chen JH, Hsu CC, Yu HJ, Nalcioglu O, Su MY. Selection of diagnostic features on breast MRI to differentiate between malignant and benign lesions using computer-aided diagnosis: differences in lesions presenting as mass and non-mass-like enhancement. Eur Radiol. 2010 Apr; 20(4):771-81. PMID: 19789878; PMCID: PMC2835636.
    37. McLaren CE, Chen WP, Nie K, Su MY. Prediction of malignant breast lesions from MRI features: a comparison of artificial neural network and logistic regression techniques. Acad Radiol. 2009 Jul; 16(7):842-51. PMID: 19409817; PMCID: PMC2832583.
    38. Carpenter PM, Chen WP, Mendez A, McLaren CE, Su MY. Angiogenesis in the progression of breast ductal proliferations. Int J Surg Pathol. 2011 Jun; 19(3):335-41. PMID: 19403546; PMCID: PMC3771508.
    39. Agrawal G, Su MY, Nalcioglu O, Feig SA, Chen JH. Significance of breast lesion descriptors in the ACR BI-RADS MRI lexicon. Cancer. 2009 Apr 01; 115(7):1363-80. PMID: 19197974; PMCID: PMC2748779.
    40. Bahri S, Chen JH, Mehta RS, Carpenter PM, Nie K, Kwon SY, Yu HJ, Nalcioglu O, Su MY. Residual breast cancer diagnosed by MRI in patients receiving neoadjuvant chemotherapy with and without bevacizumab. Ann Surg Oncol. 2009 Jun; 16(6):1619-28. PMID: 19333654; PMCID: PMC2786305.
    41. Baek HM, Chen JH, Nie K, Yu HJ, Bahri S, Mehta RS, Nalcioglu O, Su MY. Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy. Radiology. 2009 Jun; 251(3):653-62. PMID: 19276320; PMCID: PMC2687529.
    42. Chen JH, Feig BA, Hsiang DJ, Butler JA, Mehta RS, Bahri S, Nalcioglu O, Su MY. Impact of MRI-evaluated neoadjuvant chemotherapy response on change of surgical recommendation in breast cancer. Ann Surg. 2009 Mar; 249(3):448-54. PMID: 19247033; PMCID: PMC2789298.
    43. Wang H, Golob E, Bert A, Nie K, Chu Y, Dick MB, Mandelkern M, Su MY. Alterations in regional brain volume and individual MRI-guided perfusion in normal control, stable mild cognitive impairment, and MCI-AD converter. J Geriatr Psychiatry Neurol. 2009 Mar; 22(1):35-45. PMID: 19150973.
      View in: PubMed
    44. Nie K, Chen JH, Chan S, Chau MK, Yu HJ, Bahri S, Tseng T, Nalcioglu O, Su MY. Development of a quantitative method for analysis of breast density based on three-dimensional breast MRI. Med Phys. 2008 Dec; 35(12):5253-62. PMID: 19175084; PMCID: PMC2673600.
    45. Nie K, Chen JH, Yu HJ, Chu Y, Nalcioglu O, Su MY. Quantitative analysis of lesion morphology and texture features for diagnostic prediction in breast MRI. Acad Radiol. 2008 Dec; 15(12):1513-25. PMID: 19000868; PMCID: PMC2791407.
    46. Chen JH, Nalcioglu O, Su MY. Fibrocystic change of the breast presenting as a focal lesion mimicking breast cancer in MR imaging. J Magn Reson Imaging. 2008 Dec; 28(6):1499-505. PMID: 19025938; PMCID: PMC2597344.
    47. Baek HM, Chen JH, Yu HJ, Mehta R, Nalcioglu O, Su MY. Detection of choline signal in human breast lesions with chemical-shift imaging. J Magn Reson Imaging. 2008 May; 27(5):1114-21. PMID: 18425841; PMCID: PMC2613433.
    48. Chen JH, Liu H, Baek HM, Nalcioglu O, Su MY. Magnetic resonance imaging features of fibrocystic change of the breast. Magn Reson Imaging. 2008 Nov; 26(9):1207-14. PMID: 18436406; PMCID: PMC2613187.
    49. Chen JH, Baek HM, Nalcioglu O, Su MY. Estrogen receptor and breast MR imaging features: a correlation study. J Magn Reson Imaging. 2008 Apr; 27(4):825-33. PMID: 18383260; PMCID: PMC2613434.
    50. Chen JH, Feig B, Feig B, Agrawal G, Yu H, Carpenter PM, Mehta RS, Nalcioglu O, Su MY. MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy. Cancer. 2008 Jan 01; 112(1):17-26. PMID: 18000804.
      View in: PubMed
    51. Baek HM, Yu HJ, Chen JH, Nalcioglu O, Su MY. Quantitative correlation between (1)H MRS and dynamic contrast-enhanced MRI of human breast cancer. Magn Reson Imaging. 2008 May; 26(4):523-31. PMID: 18060716; PMCID: PMC2653063.
    52. Yamamoto M, Mehta RS, Baick CH, Su MY, Lane KT, Butler JA, Hsiang DJ. The predictive value of sentinel lymph node biopsy in locally advanced breast cancer patients who have undergone neoadjuvant chemotherapy. Am Surg. 2007 Oct; 73(10):977-80. PMID: 17983061.
      View in: PubMed
    53. Yu HJ, Chen JH, Mehta RS, Nalcioglu O, Su MY. MRI measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy. J Magn Reson Imaging. 2007 Sep; 26(3):615-23. PMID: 17729334.
      View in: PubMed
    54. Hsiang DJ, Yamamoto M, Mehta RS, Su MY, Baick CH, Lane KT, Butler JA. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab. Arch Surg. 2007 Sep; 142(9):855-61; discussion 860-1. PMID: 17875840.
      View in: PubMed
    55. Agrawal G, Chen JH, Baick CH, Chen AE, Mehta RS, Nalcioglu O, Su MY. Pathological complete response in triple negative poorly differentiated invasive ductal breast carcinoma detected during pregnancy. J Clin Oncol. 2007 Jun 20; 25(18):2618-20. PMID: 17577043.
      View in: PubMed
    56. Nishi RA, Liu H, Chu Y, Hamamura M, Su MY, Nalcioglu O, Anderson AJ. Behavioral, histological, and ex vivo magnetic resonance imaging assessment of graded contusion spinal cord injury in mice. J Neurotrauma. 2007 Apr; 24(4):674-89. PMID: 17439350.
      View in: PubMed
    57. Ray KM, Wang H, Chu Y, Chen YF, Bert A, Hasso AN, Su MY. Mild cognitive impairment: apparent diffusion coefficient in regional gray matter and white matter structures. Radiology. 2006 Oct; 241(1):197-205. PMID: 16990677.
      View in: PubMed
    58. Wang H, Golob EJ, Su MY. Vascular volume and blood-brain barrier permeability measured by dynamic contrast enhanced MRI in hippocampus and cerebellum of patients with MCI and normal controls. J Magn Reson Imaging. 2006 Sep; 24(3):695-700. PMID: 16878309.
      View in: PubMed
    59. Su MY, Baik HM, Yu HJ, Chen JH, Mehta RS, Nalcioglu O. Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI. Technol Cancer Res Treat. 2006 Aug; 5(4):401-10. PMID: 16866570.
      View in: PubMed
    60. Chu Y, Su MY, Mandelkern M, Nalcioglu O. Resolution improvement in positron emission tomography using anatomical Magnetic Resonance Imaging. Technol Cancer Res Treat. 2006 Aug; 5(4):311-7. PMID: 16866561.
      View in: PubMed
    61. Chen YF, Wang H, Chu Y, Huang YC, Su MY. Regional quantification of white matter hyperintensity in normal aging, mild cognitive impairment, and Alzheimer's disease. Dement Geriatr Cogn Disord. 2006; 22(2):177-84. PMID: 16912479.
      View in: PubMed
    62. Tapp PD, Head K, Head E, Milgram NW, Muggenburg BA, Su MY. Application of an automated voxel-based morphometry technique to assess regional gray and white matter brain atrophy in a canine model of aging. Neuroimage. 2006 Jan 01; 29(1):234-44. PMID: 16275022.
      View in: PubMed
    63. Hsiang D, Shah N, Yu H, Su MY, Cerussi A, Butler J, Baick C, Mehta R, Nalcioglu O, Tromberg B. Coregistration of dynamic contrast enhanced MRI and broadband diffuse optical spectroscopy for characterizing breast cancer. Technol Cancer Res Treat. 2005 Oct; 4(5):549-58. PMID: 16173825.
      View in: PubMed
    64. Su MY, Yu HJ, Carpenter PM, McLaren CE, Nalcioglu O. Pharmacokinetic parameters analyzed from mr contrast enhancement kinetics of multiple malignant and benign breast lesions detected in the same patients. Technol Cancer Res Treat. 2005 Jun; 4(3):255-63. PMID: 15896081.
      View in: PubMed
    65. Su MY, Tapp PD, Vu L, Chen YF, Chu Y, Muggenburg B, Chiou JY, Chen C, Wang J, Bracco C, Head E. A longitudinal study of brain morphometrics using serial magnetic resonance imaging analysis in a canine model of aging. Prog Neuropsychopharmacol Biol Psychiatry. 2005 Mar; 29(3):389-97. PMID: 15795047.
      View in: PubMed
    66. Tapp PD, Chu Y, Araujo JA, Chiou JY, Head E, Milgram NW, Su MY. Effects of scopolamine challenge on regional cerebral blood volume. A pharmacological model to validate the use of contrast enhanced magnetic resonance imaging to assess cerebral blood volume in a canine model of aging. Prog Neuropsychopharmacol Biol Psychiatry. 2005 Mar; 29(3):399-406. PMID: 15795048.
      View in: PubMed
    67. Tapp PD, Siwak CT, Gao FQ, Chiou JY, Black SE, Head E, Muggenburg BA, Cotman CW, Milgram NW, Su MY. Frontal lobe volume, function, and beta-amyloid pathology in a canine model of aging. J Neurosci. 2004 Sep 22; 24(38):8205-13. PMID: 15385603.
      View in: PubMed
    68. Samoszuk M, Deng T, Hamamura MJ, Su MY, Asbrock N, Nalcioglu O. Increased blood clotting, microvascular density, and inflammation in eotaxin-secreting tumors implanted into mice. Am J Pathol. 2004 Aug; 165(2):449-56. PMID: 15277219; PMCID: PMC1618560.
    69. Su MY, Cheung YC, Fruehauf JP, Yu H, Nalcioglu O, Mechetner E, Kyshtoobayeva A, Chen SC, Hsueh S, McLaren CE, Wan YL. Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer. J Magn Reson Imaging. 2003 Oct; 18(4):467-77. PMID: 14508784.
      View in: PubMed
    70. Samoszuk M, Corwin M, Yu H, Wang J, Nalcioglu O, Su MY. Inhibition of thrombosis in melanoma allografts in mice by endogenous mast cell heparin. Thromb Haemost. 2003 Aug; 90(2):351-60. PMID: 12888884.
      View in: PubMed
    71. Su MY, Yu H, Chiou JY, Wang J, Nalcioglu O, Fruehauf JP, Mehta RS, Baick CH. Measurement of volumetric and vascular changes with dynamic contrast enhanced MRI for cancer therapy monitoring. Technol Cancer Res Treat. 2002 Dec; 1(6):479-88. PMID: 12625775.
      View in: PubMed
    72. Yu H, Su MY, Wang Z, Nalcioglu O. A longitudinal study of radiation-induced changes in tumor vasculature by contrast-enhanced magnetic resonance imaging. Radiat Res. 2002 Aug; 158(2):152-8. PMID: 12105984.
      View in: PubMed
    73. Su MY, Samoszuk MK, Wang J, Nalcioglu O. Assessment of protamine-induced thrombosis of tumor vessels for cancer therapy using dynamic contrast-enhanced MRI. NMR Biomed. 2002 Apr; 15(2):106-13. PMID: 11870906.
      View in: PubMed
    74. Samoszuk M, Leonor L, Espinoza F, Carpenter PM, Nalcioglu O, Su MY. Measuring microvascular density in tumors by digital dissection. Anal Quant Cytol Histol. 2002 Feb; 24(1):15-22. PMID: 11865945.
      View in: PubMed
    75. Su MY, Head E, Brooks WM, Wang Z, Muggenburg BA, Adam GE, Sutherland R, Cotman CW, Nalcioglu O. Magnetic resonance imaging of anatomic and vascular characteristics in a canine model of human aging. Neurobiol Aging. 1998 Sep-Oct; 19(5):479-85. PMID: 9880050.
      View in: PubMed